Home
Forums
New posts
Search forums
What's new
New posts
Latest activity
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Box Ox" data-source="post: 5537030" data-attributes="member: 48469"><p>Your article cites what the FDA was saying about ivermectin as of 12/10/2021:</p><p></p><p>"Currently available data do not show ivermectin is effective against COVID-19."</p><p></p><p>--------------------------------</p><p></p><p>On the other hand, this is what the NIH was saying about ivermectin as of 8/3/2021:</p><p></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/34466270/" target="_blank">Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 - PubMed (nih.gov)</a></p><h2><span style="font-size: 15px">"</span><span style="font-size: 18px">Abstract</span></h2><p>In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world's most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. <strong>Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments. Reductions in deaths correlated with the extent of IVM distributions in all 25 states with p < 0.002. Sharp reductions in morbidity using IVM were also observed in two animal models, of SARS-CoV-2 and a related betacoronavirus. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains."</strong></p><p></p><p></p><p>Lots of legitimate medical-use drugs can kill someone if taken in the wrong formulation or dosage. So which agency are we supposed to believe regarding ivermectin?</p></blockquote><p></p>
[QUOTE="Box Ox, post: 5537030, member: 48469"] Your article cites what the FDA was saying about ivermectin as of 12/10/2021: "Currently available data do not show ivermectin is effective against COVID-19." -------------------------------- On the other hand, this is what the NIH was saying about ivermectin as of 8/3/2021: [URL='https://pubmed.ncbi.nlm.nih.gov/34466270/']Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 - PubMed (nih.gov)[/URL] [HEADING=1][SIZE=4]"[/SIZE][SIZE=5]Abstract[/SIZE][/HEADING] In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world's most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. [B]Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM treatments in Peru, excess deaths fell by a mean of 74% over 30 days in its ten states with the most extensive treatments. Reductions in deaths correlated with the extent of IVM distributions in all 25 states with p < 0.002. Sharp reductions in morbidity using IVM were also observed in two animal models, of SARS-CoV-2 and a related betacoronavirus. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains."[/B] Lots of legitimate medical-use drugs can kill someone if taken in the wrong formulation or dosage. So which agency are we supposed to believe regarding ivermectin? [/QUOTE]
Insert quotes…
Verification
Post reply
Home
Forums
Brown Cafe Community Center
Current Events
Coronavirus
Top